Rani Therapeutics Holdings (RANI) Times Interest Earned (2020 - 2025)
Historic Times Interest Earned for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to -$10.01.
- Rani Therapeutics Holdings' Times Interest Earned fell 1342.41% to -$10.01 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.19, marking a year-over-year decrease of 2248.41%. This contributed to the annual value of -$10.59 for FY2024, which is 1850.89% up from last year.
- Latest data reveals that Rani Therapeutics Holdings reported Times Interest Earned of -$10.01 as of Q3 2025, which was down 1342.41% from -$11.98 recorded in Q2 2025.
- Rani Therapeutics Holdings' 5-year Times Interest Earned high stood at $13362.0 for Q4 2021, and its period low was -$252.55 during Q3 2021.
- For the 5-year period, Rani Therapeutics Holdings' Times Interest Earned averaged around $755.9, with its median value being -$13.31 (2024).
- The largest annual percentage gain for Rani Therapeutics Holdings' Times Interest Earned in the last 5 years was 1577548.54% (2021), contrasted with its biggest fall of 47175.42% (2021).
- Over the past 5 years, Rani Therapeutics Holdings' Times Interest Earned (Quarter) stood at $13362.0 in 2021, then tumbled by 100.18% to -$24.31 in 2022, then surged by 57.37% to -$10.37 in 2023, then decreased by 28.38% to -$13.31 in 2024, then rose by 24.78% to -$10.01 in 2025.
- Its Times Interest Earned was -$10.01 in Q3 2025, compared to -$11.98 in Q2 2025 and -$12.74 in Q1 2025.